Evaluation of two rapid assays for detection of Clostridium difficile toxin A in stool specimens

Journal of Clinical Microbiology

Volumn 37, Issue 9, 1999, Pages 3044-3047

  Fedorko, Daniel P ^a   Engler, Howard D ^a,c   O'Shaughnessy, Elizabeth M ^a   Williams, Esther C ^a   Reichelderfer, Cynthia J ^b   Smith Jr , William I ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b SUBURBAN HOSPITAL   (United States)

^c MRL Reference Laboratory   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DEVICE; DIARRHEA; FECES ANALYSIS; IMMUNOASSAY; LABORATORY DIAGNOSIS; NONHUMAN; PRIORITY JOURNAL; TOXIN ANALYSIS;

CLOSTRIDIUM DIFFICILE;

EID: 0032780989     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.9.3044-3047.1999     Document Type: Article

References (23)

1. Barbut, F., C. Kajzer, M. Planas, and J.-C. Petit. 1993. Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. 31:963-967.
2. Borek, A. P., A. R. Kini, P. J. Kelly, L. Wunderlich-Wciorka, and L. R. Peterson. 1998. Prospective comparison of Clearview C. DIFF A (CDA) with Meridian Immunocard (IMM), stool culture (SIC) and cytotoxin detection (CyD) for diagnosis of Clostridium difficile associated diarrhea (CDAD), abstr. C-197, p. 163. In Abstracts of the 98th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
3. Butler, R. C., and C. T. Murphy. 1996. Performance of Immunocard Toxin A for the rapid detection of C. difficile in stool, abstr. C-347, p. 62. In Abstracts of the 96th General Meeting of the American Society for Microbiology 1996. American Society for Microbiology, Washington, D.C.
4. Campbell, M., M. Peebles, L. Cole, J. Olsen, R. Dworkin, and C. Gleaves. 1996. Comparison of the Premier and Toxin CD EIA tests and the cytotoxin assay for the detection of C. difficile, abstr. C-349, p. 63. In Abstracts of the 96th General Meeting of the American Society for Microbiology 1996. American Society for Microbiology, Washington, D.C.
5. Cohen, S. H., Y. J. Tang, B. Hansen, and J. Silva, Jr. 1998. Isolation of a toxin B-deficient mutant strain of Clostridium difficile in a case of recurrent C. difficile-associated diarrhea. Clin. Infect. Dis. 26:410-412.
6. De Girolami, P. C., P. A. Hanff, K. Eichelberger, L. Longhi, H. Teresa, J. Pratt, A. Cheng, J. M. Letourneau, and G. M. Thorne. 1992. Multicenter evaluation of a new enzyme immunoassay for detection of Clostridium difficile enterotoxin A. J. Clin. Microbiol. 30:1085-1088.
7. DiPersio, J. R., C. H. Cunliffe, and S. L. Klespies. 1996. Clinical evaluation of the ImmunoCard Toxin A EIA as an aid in the diagnosis of Clostridium difficile-associated diarrhea, abstr. C-344, p. 62. In Abstracts of the 96th General Meeting of the American Society for Microbiology 1996. American Society for Microbiology, Washington, D.C.
8. Doing, K. M. 1998. Prospective evaluation of five enzyme-immunoassays for the detection of Clostridium difficile toxin A, abstr. C-188, p. 162. In Abstracts of the 98th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
9. Fedorko, D. P., and E. C. Williams. 1997. Use of cycloserine-cefoxitin-fructose agar and L-proline-aminopeptidase (PRO discs) in the rapid identification of Clostridium difficile. J. Clin. Microbiol. 35:1258-1259.
10. Fekety, R., L. V. McFarland, C. M. Surawicz, R. N. Greenberg, G. W. Elmer, and M. E. Mulligan. 1997. Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin. Infect. Dis. 24:324-333.
11. Garcia, A., T. Garcia, and J. L. Pérez. 1997. Proline-aminopeptidase test for rapid screening of Clostridium difficile. J. Clin. Microbiol. 35:3007.
12. Goodpasture, H. C., and K. S. Bridge. 1998. Clostridium difficile testing: combining culture with toxin detection for optimal accuracy at minimum cost, abstr. 763 Sa, p. 218. In Program and abstracts of the 36th Annual Meeting of the Infectious Diseases Society of America. Infectious Diseases Society of America, Alexandria, Va.
13. Greene, W., B. Oren, J. Anderson, C. Peters, and C. Dively. 1998. Prospective clinical evaluation of a new rapid methodology for detecting Clostridium difficile toxin A in stool, abstr. C-183, p. 161. In Abstracts of the 98th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.
14. Hu, J. K., P. A. Becker, R. T. Bechard, and D. H. Willis. 1994. Limit of detection of EIA kits for Clostridium difficile toxin A and relevance to toxin detection in stools, abstr. C-12, p. 492. In Abstracts of the 94th General Meeting of the American Society for Microbiology 1994. American Society for Microbiology, Washington, D.C.
15. Kader, H. A., D. A. Piccoli, A. F. Jawad, K. L. McGowan, and E. S. Maller. 1998. Single toxin detection is inadequate to diagnose Clostridium difficile diarrhea in pediatric patients. Gastroenterology 115:1329-1334.
16. Kelly, C. P., C. Pothoulakis, and J. T. LaMont. 1994. Clostridium difficile colitis. N. Engl. J. Med. 330:257-262.
17. Knoop, F. C., M. Owens, and I. C. Crocker. 1993. Clostridium difficile: clinical disease and diagnosis. Clin. Microbiol. Rev. 6:251-265.
18. Lyerly, D. M., L. A. Barroso, T. D. Wilkins, C. Depitre, and G. Corthier. 1992. Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile. Infect. Immun. 60:4633-4639.
19. Peterson, L. R., P. J. Kelly, and H. A. Nordbrock. 1996. Role of culture and toxin detection in laboratory testing for diagnosis of Clostridium difficile-associated diarrhea. Eur. J. Clin. Microbiol. Infect. Dis. 15:330-336.
20. Peterson, L. R., M. M. Olson, C. J. Shanholtzer, and D. N. Gerding. 1988. Results of a prospective, 18-month clinical evaluation of culture, cytotoxin testing, and Culturette brand (CDT) latex testing in the diagnosis of Clostridium difficile-associated diarrhea. Diagn. Microbiol. Infect. Dis. 10:85-91.
21. Rolfe, R., and J. Colmer. 1996. Evaluation of Immunocard Toxin A, a rapid enzyme immunoassay for the detection of Clostridium difficile toxin A in human stool, abstr. C-345, p. 62. In Abstracts of the 96th General Meeting of the American Society for Microbiology 1996. American Society for Microbiology, Washington, D.C.
22. Staneck, J. L., L. S. Weckbach, S. D. Allen, J. A. Siders, P. H. Gilligan, G. Coppitt, J. A. Kraft, and D. H. Willis. 1996. Multicenter evaluation of four methods for Clostridium difficile detection: ImmunoCard C. difficile, cytotoxin assay, culture, and latex agglutination. J. Clin. Microbiol. 34:2718-2721.
23. Szeto, S., R. P. Rennie, and E. Prasad. 1997. Evaluation of four Clostridium difficile EIA toxin assays with cytotoxicity assay and bacterial culture using clinical criteria to assess diagnostic utility, abstr. D-158, p. 111. In Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.